Picture of Solid Biosciences logo

SLDB Solid Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Solid Biosciences Says Ends Q1 With About $185.5 Mln In Cash

May 11 (Reuters) - Solid Biosciences Inc  SLDB.O :
    * SOLID BIOSCIENCES INC SAYS ENDS Q1 WITH ABOUT $185.5
MILLION IN
CASH AND INVESTMENTS; ANTICIPATED CASH RUNWAY INTO 2025
    * SOLID BIOSCIENCES INC SAYS NO COLLABORATION REVENUES FOR
Q1 OF
2023
    * SOLID BIOSCIENCES INC SAYS NET LOSS FOR Q1 OF 2023 WAS
$30.1
MILLION

Source text for Eikon:  ID:nGNX6Lq190 
Further company coverage:  SLDB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Solid Biosciences

See all news